Loading...
Market
What will be Centessa ($CNTA) stock price by end of 2024?
3
Resolution / Starting Odds
Above $50 • 25%
Between $30 and $50 • 25%
Between $10 and $30 • 25%
Below $10 • 25%
Stock market data from a reputable financial source like Bloomberg or Yahoo Finance
Story
Centessa ($CNTA) Hits Three-Year High on Positive Phase 1 Data for ORX750
Sep 10, 2024, 02:21 PM
Centessa Pharmaceuticals ($CNTA) has announced positive interim Phase 1 clinical data for its novel Orexin Receptor 2 (OX2R) agonist, ORX750. The study involved acutely sleep-deprived healthy volunteers and has shown promising results. This development has propelled Centessa's stock to a three-year high, highlighting a significant $5 billion opportunity in the narcolepsy market. The milestone was celebrated by the Centessa team, including Mario Accardi.
View original story
Similar markets
Decrease by more than 5% • 25%
Change by -5% to +5% • 25%
Increase by 5% to 10% • 25%
Increase by more than 10% • 25%
Increases by 20% or more • 25%
Increases by less than 20% • 25%
Remains stable • 25%
Decreases • 25%
Below $2 • 25%
$2 to $5 • 25%
Above $10 • 25%
Below $5 • 25%
$5 to $10 • 25%
$10 to $15 • 25%
Above $15 • 25%
Below $150 • 25%
$150 - $175 • 25%
$175 - $200 • 25%
Above $200 • 25%
Below $20 • 25%
$20 to $40 • 25%
$40 to $60 • 25%
Above $60 • 25%
Above $25 • 25%
$20 - $25 • 25%
$15 - $20 • 25%
Below $15 • 25%
Less than $20 • 25%
$20 to $30 • 25%
$30 to $40 • 25%
More than $40 • 25%
Less than $500 million • 25%
$500 million to $1 billion • 25%
$1 billion to $5 billion • 25%
More than $5 billion • 25%
Less than 50% • 25%
50% to 100% • 25%
100% to 200% • 25%
More than 200% • 25%